Cardiogenic shock severity and mortality in patients receiving venoarterial extracorporeal membrane oxygenator support.

Cardiogenic shock Extracorporeal life support Extracorporeal membrane oxygenator Mechanical circulatory support Shock Vasopressors

Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
27 Dec 2022
Historique:
received: 04 06 2022
revised: 17 07 2022
accepted: 26 09 2022
pubmed: 30 9 2022
medline: 30 12 2022
entrez: 29 9 2022
Statut: ppublish

Résumé

Shock severity predicts mortality in patients with cardiogenic shock (CS). We evaluated the association between pre-cannulation Society for Cardiovascular Angiography and Intervention (SCAI) shock classification and mortality among patients receiving venoarterial (VA) extracorporeal membrane oxygenation (ECMO) support for CS. We included Extracorporeal Life Support Organization (ELSO) Registry patients from 2010 to 2020 who received VA ECMO for CS. SCAI shock stage was assigned based on hemodynamic support requirements prior to ECMO initiation. In-hospital mortality was analyzed using multivariable logistic regression. We included 12 106 unique VA ECMO patient runs with a median age of 57.9 (interquartile range: 46.8, 66.1) years and 31.8% were females; 3472 (28.7%) were post-cardiotomy. The distribution of SCAI shock stages at ECMO initiation was: B, 821 (6.8%); C, 7518 (62.1%); D, 2973 (24.6%); and E, 794 (6.6%). During the index hospitalization, 6681 (55.2%) patients died. In-hospital mortality increased incrementally with SCAI shock stage (adjusted OR: 1.24 per SCAI shock stage, 95% CI: 1.17-1.32, P < 0.001): B, 47.5%; C, 52.8%; D, 60.8%; E, 65.1%. A higher SCAI shock stage was associated with increased in-hospital mortality in key subgroups, although the SCAI shock classification was only predictive of mortality in non-surgical (medical) CS and not in post-cardiotomy CS. The severity of shock prior to cannulation is a strong predictor of in-hospital mortality in patients receiving VA ECMO for CS. Using the pre-cannulation SCAI shock classification as a risk stratification tool can help clinicians refine prognostication for ECMO recipients and guide future investigations to improve outcomes.

Identifiants

pubmed: 36173885
pii: 6731283
doi: 10.1093/ehjacc/zuac119
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

891-903

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Auteurs

Jacob C Jentzer (JC)

Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

David A Baran (DA)

Heart and Vascular Institute, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA.

J Kyle Bohman (J)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Sean van Diepen (S)

Extracorporeal Life Support Organization (ELSO), ELSO Office, 3001 Miller Road, Ann Arbor, MI 48103, USA.

Misty Radosevich (M)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Suraj Yalamuri (S)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Peter Rycus (P)

Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, 8440 112 St NW, Edmonton, AB T6G 2B7, Canada.

Stavros G Drakos (SG)

Divisions of Cardiothoracic Surgery and Emergency Medicine, University of Utah Hospital, 50 Medical Dr N, Salt Lake City, UT 84132, USA.

Joseph E Tonna (JE)

Divisions of Cardiothoracic Surgery and Emergency Medicine, University of Utah Hospital, 50 Medical Dr N, Salt Lake City, UT 84132, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH